Mjali, A. (2022) “Treatment Outcomes of Nilotinib as Second Line Therapy for Chronic Myeloid Leukemia Patients in Karbala Province of Iraq”, Asian Pacific Journal of Cancer Care, 7(2), pp. 267–272. doi: 10.31557/apjcc.2022.7.2.267-272.